Ignite Creation Date:
2025-12-24 @ 7:56 PM
Ignite Modification Date:
2025-12-25 @ 5:31 PM
Study NCT ID:
NCT04043104
Status:
COMPLETED
Last Update Posted:
2023-04-24
First Post:
2019-07-23
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Phase 1 Open-Label, Dose Escalation Study to Determine the Optimal Dose, Safety, and Activity of AAV2hAQP1 in Subjects With Radiation-Induced Parotid Gland Hypofunction and Xerostomia
Sponsor:
MeiraGTx UK II Ltd
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-06-30
Start Date Type:
ACTUAL
Primary Completion Date:
2023-03-28
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-03-28
Completion Date Type:
ACTUAL
First Submit Date:
2019-07-23
First Submit QC Date:
None
Study First Post Date:
2019-08-02
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-04-21
Last Update Post Date:
2023-04-24
Last Update Post Date Type:
ACTUAL